Keywords

• Artemisinin
• Artemisinin powder
• 99% Artemisinin

Quick Details

• ProName: cas 1985606-14-1 99% Baloxavir marbox...
• CasNo: 63968-64-9
• Molecular Formula: C15H22O5
• Appearance: white
• Application: Artemisia annua is used as antimalaria...
• DeliveryTime: 7-10 days
• PackAge: drum
• Port: Shanghai/Wuhan
• ProductionCapacity: 1000 Kilogram/Day
• Purity: 99
• Storage: room
• LimitNum: 1 Kilogram

Superiority

cas 1985606-14-1 99%  Baloxavir marboxil powder 

Product Name:    Baloxavir marboxil
CAS:    1985606-14-1
MF:    C27H23F2N3O7S
MW:    571.55

Baloxavir marboxil is an antiviral drug and Roche for the treatment of influenza A and influenza B infections. The drug was initially approved for use in Japan in February 2018 and approved by the FDA on October 24, 2018 for the treatment of acute uncomplicated influenza in patients 12 years of age and older who have been symptomatic for no more than 48 hours Label. Baloxavir marboxil, a cap-endonuclease inhibitor, has a unique mechanism of action when compared to the currently existing neuraminidase inhibitor drug class used to treat influenza infections.
Baloxavir marboxil is an influenza medication, an antiviral, 

Details

cas 1985606-14-1 99%  Baloxavir marboxil powder 

Product Name:    Baloxavir marboxil
CAS:    1985606-14-1
MF:    C27H23F2N3O7S
MW:    571.55

Baloxavir marboxil is an antiviral drug and Roche for the treatment of influenza A and influenza B infections. The drug was initially approved for use in Japan in February 2018 and approved by the FDA on October 24, 2018 for the treatment of acute uncomplicated influenza in patients 12 years of age and older who have been symptomatic for no more than 48 hours Label. Baloxavir marboxil, a cap-endonuclease inhibitor, has a unique mechanism of action when compared to the currently existing neuraminidase inhibitor drug class used to treat influenza infections.
Baloxavir marboxil is an influenza medication, an antiviral,